Ernexa Therapeutics Inc.

8-K Regulation FD disclosure Jul 2, 2026 8-K Shareholder vote results Jul 2, 2026 8-K Director or officer change Jun 26, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Amended charter or bylaws May 4, 2026 8-K Delisting notice or listing-rule failure Mar 20, 2026 10-K Fiscal year ended 2025-12-31 Mar 13, 2026 8-K Regulation FD disclosure Feb 26, 2026 8-K Entered a material agreement; Other events Feb 11, 2026 8-K Regulation FD disclosure Dec 11, 2025 10-Q Quarter ended 2025-09-30 Nov 7, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Changed accountants Jul 7, 2025 8-K Amended charter or bylaws Jun 12, 2025 8-K Unregistered sale of equity; Other events Jun 9, 2025 8-K Amended charter or bylaws; Shareholder vote results Jun 2, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Entered a material agreement; Unregistered sale of equity; Item 5.08 Apr 3, 2025 8-K Amended charter or bylaws Mar 26, 2025 8-K Entered a material agreement; Took on a direct financial obligation Mar 24, 2025 10-K Fiscal year ended 2024-12-31 Mar 12, 2025 8-K Entered a material agreement; Took on a direct financial obligation Mar 12, 2025 8-K Item 5.08 Feb 13, 2025 8-K Delisting notice or listing-rule failure; Director or officer change Jan 10, 2025 8-K Delisting notice or listing-rule failure Jan 3, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Entered a material agreement; Unregistered sale of equity; Shareholder vote results; Other events Oct 29, 2024 8-K Entered a material agreement; Terminated a material agreement Sep 27, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Sep 25, 2024 8-K Delisting notice or listing-rule failure Sep 23, 2024 8-K Other events Aug 19, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Delisting notice or listing-rule failure Mar 22, 2024 10-K/A Fiscal year ended 2023-12-31 Mar 18, 2024 10-K Fiscal year ended 2023-12-31 Mar 14, 2024 8-K Director or officer change Feb 16, 2024 8-K Delisting notice or listing-rule failure Jan 19, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Director or officer change; Other events Dec 20, 2023 8-K Entered a material agreement; Took on a direct financial obligation Dec 14, 2023